Projects & Working Groups

  • Appendiceal NET – Are we overtreating?
  • Financial Toxicity of NET.
  • MEN Database.
  • Recommendations for optimal clinical trial design in (advanced) NETs: consensus recommendations for trial endpoints from the CommNETS collaboration.
  • Making pNETs immunogenic.
  • NET classification by cell type
  • PRRT and QOL.
  • Design and creation of an optimal shared care model for NETS patients in the community.
  • Systematic review of surgical trials in NET.
  • Pituitary dysfunction after PRRT
  • Identifying outcomes that are meaningful to patients
  • Paediatrics and AYA NETS
  • Identifying outcomes that are meaningful to patients
  • Checkpoint inhibitor and radiotherapy abscopal effect

For full details click here.

Share